Clinical Trial Update: Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial [Phase 2]

View source ↗

Summary

This is a Phase II follow-up study assessing the safety and efficacy of PNEUMOSTEM in subjects with Bronchopulmonary Dysplasia who completed the prior Phase II …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• PNEUMOSTEM

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Bronchopulmonary Dysplasia, BPD | Phase 2 | Status: ACTIVE_NOT_RECRUITING